Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Ohlstein

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1986
Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonistsE H Ohlstein, B A Berkowitz
The American Journal of Physiology|April 1, 1990
Dopamine-1 receptors in rat proximal convoluted tubule: regulation by intrarenal dopamineS Kinoshita, E H Ohlstein, R A Felder
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
Cellular mechanisms of endothelin in rabbit aortaE H Ohlstein, S Horohonich, D W Hay
British Journal of Pharmacology|November 1, 1987
Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscleK Shikano, E H Ohlstein, B A Berkowitz
IUBMB Life|November 22, 2000
Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophagesS K Gupta, K Pillarisetti, E H Ohlstein
Trends in Pharmacological Sciences|May 8, 2001
Therapeutic modulation of transcription factor activityJ G Emery, E H Ohlstein, M Jaye
The American Journal of Physiology|August 1, 1990
Renal microvascular effects of endothelinR M Edwards, W Trizna, E H Ohlstein
American Journal of Hypertension|March 21, 1998
Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failureR R Ruffolo, G Z Feuerstein, E H Ohlstein
Trends in Pharmacological Sciences|May 1, 1996
California dreamin' 'bout endothelin: emerging new therapeuticsT D Warner, J D Elliott, E H Ohlstein
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526E H Ohlstein, B Zabko-Potapovich, B A Berkowitz
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1986
Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonistsE H Ohlstein, B A Berkowitz
The American Journal of Physiology|April 1, 1990
Dopamine-1 receptors in rat proximal convoluted tubule: regulation by intrarenal dopamineS Kinoshita, E H Ohlstein, R A Felder
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
Cellular mechanisms of endothelin in rabbit aortaE H Ohlstein, S Horohonich, D W Hay
British Journal of Pharmacology|November 1, 1987
Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscleK Shikano, E H Ohlstein, B A Berkowitz
IUBMB Life|November 22, 2000
Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophagesS K Gupta, K Pillarisetti, E H Ohlstein
Trends in Pharmacological Sciences|May 8, 2001
Therapeutic modulation of transcription factor activityJ G Emery, E H Ohlstein, M Jaye
The American Journal of Physiology|August 1, 1990
Renal microvascular effects of endothelinR M Edwards, W Trizna, E H Ohlstein
American Journal of Hypertension|March 21, 1998
Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failureR R Ruffolo, G Z Feuerstein, E H Ohlstein
Trends in Pharmacological Sciences|May 1, 1996
California dreamin' 'bout endothelin: emerging new therapeuticsT D Warner, J D Elliott, E H Ohlstein
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526E H Ohlstein, B Zabko-Potapovich, B A Berkowitz
Pageof 17